OGEN (STOCKS)
Oragenics Inc.
$0.673100
+0.070100 (+11.63%)
Prev close: $0.603000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Janet Huffman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2.97M
- Employees
- 5
- P/E (TTM)
- -0.07
- P/B (TTM)
- 0.35
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$616.89K |
| Operating Expenses | $9.36M |
| Research and Development | $2.39M |
| Other Operating Expenses | $6.97M |
| Operating Income/Loss | -$9.36M |
| Income/Loss From Continuing Operations After Tax | -$9.98M |
| Income/Loss From Continuing Operations Before Tax | -$9.98M |
| Net Income/Loss | -$9.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$9.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$9.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.56 |
| Diluted Earnings Per Share | -$4.56 |
| Basic Average Shares | 2,157,076 |
| Diluted Average Shares | 2,157,076 |
| Assets | $10.07M |
| Current Assets | $10.07M |
| Noncurrent Assets | $0.00 |
| Liabilities | $1.79M |
| Current Liabilities | $1.79M |
| Noncurrent Liabilities | $0.00 |
| Equity | $8.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $8.28M |
| Liabilities And Equity | $10.07M |
| Net Cash Flow From Operating Activities | -$9.25M |
| Net Cash Flow From Operating Activities, Continuing | -$9.25M |
| Net Cash Flow From Investing Activities | -$7.53M |
| Net Cash Flow From Investing Activities, Continuing | -$7.53M |
| Net Cash Flow From Financing Activities | $16.78M |
| Net Cash Flow From Financing Activities, Continuing | $16.78M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$9.84M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$9.84M |
| Other Comprehensive Income/Loss | $0.00 |